| 000 | 01679 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517111543.0 | ||
| 264 | 0 | _c20180206 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-016-1525-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBush, Shirley Harvey | |
| 245 | 0 | 0 |
_aThe preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial. _h[electronic resource] |
| 260 |
_bTrials _c08 2016 |
||
| 300 |
_a399 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCentral Nervous System Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aDementia _xdiagnosis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelatonin _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aOntario |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLacaze-Masmonteil, Nathalie | |
| 700 | 1 | _aMcNamara-Kilian, Marie Theresa | |
| 700 | 1 | _aMacDonald, Alistair Richard | |
| 700 | 1 | _aTierney, Sallyanne | |
| 700 | 1 | _aMomoli, Franco | |
| 700 | 1 | _aAgar, Meera | |
| 700 | 1 | _aCurrow, David Christopher | |
| 700 | 1 | _aLawlor, Peter Gerard | |
| 773 | 0 |
_tTrials _gvol. 17 _gp. 399 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-016-1525-8 _zAvailable from publisher's website |
| 999 |
_c26319804 _d26319804 |
||